SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-068499
Filing Date
2020-06-01
Accepted
2020-06-01 17:31:05
Documents
2
Period of Report
2020-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2021119d1_3.html 3  
1 OWNERSHIP DOCUMENT tm2021119d1_3.xml 3 1613
2 EXHIBIT 24.1 tm2021119d1_ex24-1.htm EX-24.1 3431
  Complete submission text file 0001104659-20-068499.txt   6817
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 1325 AVENUE OF AMERICAS, 28TH FLR. NEW YORK NY 10019
Business Address
Lindborg Stacy (Reporting) CIK: 0001813667 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36641 | Film No.: 20934870